Loading...
XJPX6961
Market cap264mUSD
Jan 15, Last price  
4,685.00JPY
1D
0.75%
1Q
-31.00%
Jan 2017
35.80%
Name

Enplas Corp

Chart & Performance

D1W1MN
XJPX:6961 chart
P/E
12.02
P/S
1.09
EPS
389.69
Div Yield, %
1.28%
Shrs. gr., 5y
-6.81%
Rev. gr., 5y
3.86%
Revenues
37.81b
-10.50%
39,406,572,00040,189,328,00031,444,441,00029,112,914,00020,796,671,00018,221,548,00020,984,353,00020,723,236,00026,244,582,00039,529,112,00039,650,620,00038,737,000,00032,991,000,00033,288,000,00031,281,000,00031,456,000,00029,437,000,00032,894,000,00042,240,000,00037,805,000,000
Net income
3.44b
-25.49%
2,647,454,0001,506,462,00017,663,000-1,164,691,000-7,188,630,000256,866,000306,441,000963,316,0005,635,944,0009,139,314,0007,921,470,0005,592,000,0005,152,000,0002,536,000,000332,000,000489,000,000893,000,0002,528,000,0004,621,000,0003,443,000,000
CFO
8.23b
-6.05%
7,525,936,0005,877,057,0003,407,109,0003,467,590,0001,686,426,000-377,641,0002,409,101,0002,067,537,0006,894,599,00014,300,862,0008,104,346,00010,388,000,0004,098,000,0005,581,000,0003,945,000,0003,354,000,0003,921,000,0004,046,000,0008,761,000,0008,231,000,000
Dividend
Mar 28, 20250 JPY/sh

Profile

Enplas Corporation engages in the engineering plastic, semiconductor peripherals, plastic optical businesses in Japan and internationally. It offers mechanical solutions, including gears and fluid control products; semiconductor solutions comprising general-purpose IC sockets; optical solutions, such as optical devices that include lens array for parallel communications and plastic barrels; LED solutions, including controlling LED lights; and life science products comprising microfluidic chips, endotoxin-free products, and other life science-related products. The company was founded in 1962 and is headquartered in Tokyo, Japan.
IPO date
Sep 05, 1984
Employees
1,527
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
37,805,000
-10.50%
42,240,000
28.41%
32,894,000
11.74%
Cost of revenue
22,142,000
23,076,000
20,194,000
Unusual Expense (Income)
NOPBT
15,663,000
19,164,000
12,700,000
NOPBT Margin
41.43%
45.37%
38.61%
Operating Taxes
1,504,000
1,839,000
1,404,000
Tax Rate
9.60%
9.60%
11.06%
NOPAT
14,159,000
17,325,000
11,296,000
Net income
3,443,000
-25.49%
4,621,000
82.79%
2,528,000
183.09%
Dividends
(529,000)
(484,000)
(329,000)
Dividend yield
0.80%
1.12%
1.37%
Proceeds from repurchase of equity
(3,000)
1,561,000
BB yield
0.00%
-6.52%
Debt
Debt current
1,377,000
290,000
187,000
Long-term debt
3,098,000
2,398,000
1,471,000
Deferred revenue
140,000
156,000
Other long-term liabilities
276,000
155,000
85,000
Net debt
(20,868,000)
(19,465,000)
(16,065,000)
Cash flow
Cash from operating activities
8,231,000
8,761,000
4,046,000
CAPEX
(3,927,000)
(2,423,000)
(1,794,000)
Cash from investing activities
(4,089,000)
(2,581,000)
(1,576,000)
Cash from financing activities
(965,000)
(765,000)
(2,053,000)
FCF
11,742,000
15,390,000
9,706,000
Balance
Cash
24,788,000
20,766,000
14,914,000
Long term investments
555,000
1,387,000
2,809,000
Excess cash
23,452,750
20,041,000
16,078,300
Stockholders' equity
53,908,000
91,567,000
94,207,000
Invested Capital
31,213,250
27,737,000
25,922,700
ROIC
48.04%
64.57%
44.49%
ROCE
28.63%
40.09%
30.21%
EV
Common stock shares outstanding
8,991
8,828
8,823
Price
7,350.00
50.46%
4,885.00
79.93%
2,715.00
-34.50%
Market cap
66,086,033
53.24%
43,125,058
80.04%
23,953,419
-48.66%
EV
45,945,033
67,349,058
47,239,419
EBITDA
18,048,000
21,407,000
15,065,000
EV/EBITDA
2.55
3.15
3.14
Interest
76,000
66,000
58,000
Interest/NOPBT
0.49%
0.34%
0.46%